4150.Two
4150.TWO operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
Business. 4150.TWO operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
4150.TWO operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
The company's capital structure is characterized by a debt-to-equity ratio of 0.8, indicating a moderate level of leverage. However, the liquidity position is concerning, as the company has negative net cash after subtracting total debt, and the current ratio of 1.4 suggests limited short-term liquidity. The valuation snapshot reveals a return on equity of -0.5622 and a return on assets of -0.2589, both of which are significantly below the industry median, indicating poor profitability and asset utilization.
The company's profitability is severely underperforming, with a net loss of TWD 273,953,000 and an operating loss of TWD 241,075,000. These figures are far below the industry's preferred metrics, which typically emphasize positive operating margins and net profit margins. The negative returns on equity and assets further underscore the company's inability to generate returns for shareholders or effectively utilize its assets.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes.
The company's growth trajectory is negative, with a net loss in the current fiscal year and no indication of improvement in the next fiscal year. The operating cash flow is negative at TWD -184,379,000, and the free cash flow is also negative at TWD -272,712,000, indicating that the company is not generating sufficient cash to sustain operations or fund growth.
The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, suggesting potential liquidity constraints. However, the dilution risk is low, as there is no indication of imminent share issuance or dilution.
Recent events, as disclosed in the company's financial filings, include a significant net loss and negative operating and free cash flows. These events indicate financial distress and may impact the company's ability to meet its obligations and continue as a going concern.
- The company is experiencing significant financial distress, with a net loss and negative operating and free cash flows.
- The company's profitability metrics are far below industry medians, indicating poor performance.
- The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.8.
- The company's liquidity position is weak, with a current ratio of 1.4 and negative net cash after subtracting total debt.
- The company's growth trajectory is negative, with no indication of improvement in the next fiscal year.
- The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 4150.TWO Market data — financials · 2026-05-26